```json
{
"content": [
{
"type": "paragraph",
"content": "The Lyme Disease Diagnostic Service market encompasses laboratory and point-of-care testing solutions for the early detection and management of Lyme disease, a tick-borne illness driven by rising incidence and geographic expansion of vector habitats. As part of the broader infectious disease diagnostics industry, this sector is critical for reducing misdiagnosis rates and improving patient outcomes. The Lyme Disease Diagnostic Service market size is projected to exceed $480 million by 2033, reflecting a compound annual growth rate (CAGR) of 7.2% from 2026 to 2033. This expansion is underpinned by heightened awareness of Lyme disease, regulatory support for advanced diagnostics, and innovations in multiplex testing platforms."
},
{
"type": "paragraph",
"content": "Key forces shaping the Lyme Disease Diagnostic Service industry expansion include technological shifts toward high-sensitivity immunoassays and next-generation sequencing, which enhance early-stage detection accuracy. Regulatory frameworks, particularly in North America and Europe, are also driving standardization of diagnostic protocols, while supply-chain dynamics—such as rising demand for point-of-care testing kits—are accelerating market fragmentation. The U.S. remains the largest regional market, accounting for over 40% of global revenue in 2025, while Asia-Pacific is the fastest-growing region, fueled by increasing healthcare infrastructure investments and tick-borne disease awareness campaigns."
},
{
"type": "chart",
"chartType": "segment-stacked",
"data": {
"segments": ["Serological Tests", "PCR Tests", "Rapid Diagnostic Kits"],
"periods": ["2020", "2021", "2022", "2023", "2024", "2025", "2026", "2027", "2028", "2029", "2030", "2031", "2032", "2033"],
"values": [
[65, 70, 75, 80, 85, 90, 95, 100, 105, 110, 115, 120, 125, 130], // Serological
[30, 32, 35, 38, 40, 42, 45, 48, 52, 56, 60, 64, 68, 72], // PCR
[15, 18, 20, 22, 25, 28, 30, 33, 36, 40, 45, 50, 55, 60] // Rapid Kits
]
}
}
]
}
```
